Amphastar Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount
Amphastar Pharmaceuticals, Inc. (AMPH) reported Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount of $100.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-15.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlementsStateAndLocal · last filed 2021-03-15
- Amphastar Pharmaceuticals, Inc. effective income tax rate reconciliation, tax settlement, state and local, amount for fiscal 2018 was $100.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount 12 month |
|---|---|
| 2018-12-31 | $100.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |